Differential function of major histocompatibility complex antigens in T-lymphocyte activation.

Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci U S A (1978) 8.72

Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med (1982) 5.09

The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27

Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med (1980) 3.00

Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function. Proc Natl Acad Sci U S A (1981) 2.95

Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med (1979) 1.88

Detergent-soluble HLA antigens contain a hydrophilic region at the COOH-terminus and a penultimate hydrophobic region. Proc Natl Acad Sci U S A (1976) 1.82

Cytolytic thymus-derived lymphocytes specific for allogeneic stimulator cells crossreact with chemically modified syngeneic cells. Proc Natl Acad Sci U S A (1977) 1.71

Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatibility complex-restricted responses. J Exp Med (1983) 1.56

Alternative pathways of T lymphocyte activation. J Exp Med (1978) 1.49

Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones. J Exp Med (1985) 1.46

Antibody response of mice to chemically induced tumors. Proc Natl Acad Sci U S A (1978) 1.41

Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Proc Natl Acad Sci U S A (1977) 1.38

Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles. Proc Natl Acad Sci U S A (1978) 1.37

Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med (1980) 1.35

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med (1990) 1.35

Dissociation and exchange of the beta 2-microglobulin subunit of HLA-A and HLA-B antigens. Proc Natl Acad Sci U S A (1979) 1.31

Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus. J Exp Med (1983) 1.30

Induction of specific immune unresponsiveness with purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. II. An analysis of the effects measured at the cellular and serological levels. J Exp Med (1978) 1.25

Induction of specific immune unresponsiveness using purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. I. Demonstration of general validity as to species and histocompatibility barriers. J Exp Med (1977) 1.16

Effects of Lyt antibodies on T-cell functions: augmentation by anti-Lyt-1 as opposed to inhibition by anti-Lyt-2. Proc Natl Acad Sci U S A (1981) 1.10

Idiotypic determinants on T-cell subpopulations. J Exp Med (1979) 1.08

Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation. J Exp Med (1980) 1.08

Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products. J Exp Med (1977) 1.08

Key antigenic determinants in regulation of the immune response. Proc Natl Acad Sci U S A (1977) 1.02

Enhancement of T lymphocyte functions by Fc fragments of immunoglobulins. I. Augmentation of allogeneic mixed lymphocyte culture reactions requires I-A- or I-B-subregion differences between effector and stimulator cell populations. J Exp Med (1981) 1.01

Activation of antigen-specific suppressor T cells in the presence of cyclosporin requires interactions between T cells of inducer and suppressor lineage. J Clin Invest (1983) 1.00

Alloreactive cytotoxic T lymphocyte responses to H-2 products on purified accessory cells. Immunology (1982) 1.00

Chick embryo pancreatic transplants reverse experimental diabetes of rats. J Clin Invest (1979) 0.99

Nuclear morphology and morphometry of B-lymphocyte transformation. Implications for follicular center cell lymphomas. Am J Pathol (1983) 0.98

Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes. J Exp Med (1979) 0.97

Cellular basis of the proliferative response of human T cells to mouse xenoantigens. J Exp Med (1990) 0.95

Helper cell-independent cytotoxic clones in man. J Exp Med (1982) 0.95

Induction of cytotoxic T cell precursors in vivo. Role of T helper cells. J Exp Med (1983) 0.95

Restricted and conserved T-cell repertoires involved in allorecognition of class II major histocompatibility complex. Proc Natl Acad Sci U S A (1995) 0.92

Inhibition of vessel allograft rejection by endothelial removal. Morphologic and ultrastructural changes. Ann Surg (1987) 0.91

Localization of paternal H-2K antigens on murine trophoblast cells in vivo. J Exp Med (1982) 0.91

Differential effects of polyadenylic: polyuridylic acid and lipopolysaccharide on the generation of cytotoxic T lymphocytes. J Exp Med (1978) 0.90

Specific suppression of allograft rejection by trinitrophenyl (TNP)-induced suppressor cells in recipients treated with TNP-haptenated donor alloantigens. J Exp Med (1985) 0.88

In vitro sensitization of thymocytes. Role of H-21 I region determinants and cell-free mixed leukocyte culture supernates in generation of cytotoxic responses. J Exp Med (1978) 0.87

Cell contact-mediated macrophage activation for antileishmanial defence: mapping of the genetic restriction to the I region of the MHC. Clin Exp Immunol (1985) 0.87

HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro. J Clin Invest (1983) 0.85

Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4. Clin Exp Immunol (1981) 0.84

In vivo separation of two classes of T cells as determined by negative selection after the injection of UV-treated allogeneic lymphoid cells. Proc Natl Acad Sci U S A (1985) 0.82

T-cell activation, proliferation, and memory after cardiac transplantation in vivo. Ann Surg (1999) 0.82

Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status. Immunology (1994) 0.80

Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation. Yale J Biol Med (1991) 0.80

Regulatory mechanisms in cell-mediated immune responses. Role of I-J and I-C determinants in the activation of H-2I and H-2K/D alloantigen-specific suppressor T cells. J Exp Med (1983) 0.79

Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc Natl Acad Sci U S A (1991) 0.78

The mediator of cellular immunity. XII. Inhibition of activated T cells by Newcastle disease virus. J Exp Med (1976) 0.78

Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells. J Exp Med (1977) 0.78

T cells can be cytotoxic without making interleukin 2: a model of separate pathways of induction. Proc Natl Acad Sci U S A (1986) 0.77

The frequency of clones of cytotoxic lymphocytes generated by H-2 antigens. J Exp Med (1978) 0.77

Biological effects of allogeneic effect factor on T lymphocytes: in vitro induction of cytotoxic T lymphocytes manifesting preferential lytic activity against H-2-identical tumor cells. Proc Natl Acad Sci U S A (1979) 0.77

The cells involved in cell-mediated and transplantation immunity in the normal outbred rabbit. X. The organ sources of the stimulator and responder cells in the mixed leukocyte culture reaction. Immunology (1979) 0.76

The class III histone deacetylase sirtuin 1 in immune suppression and its therapeutic potential in rheumatoid arthritis. J Genet Genomics (2013) 0.76

Cellular basis of neonatal induction of in vitro tolerance. J Exp Med (1976) 0.75

Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications. J Immunol Res (2017) 0.75

Thymus-derived macrophages in long-term culture: release of IL-1, stimulation of MLR and expression of tumoricidal activity. Immunology (1985) 0.75

The cells involved in cell-mediated and transplantation immunity in the normal outbred rabbit. XI. The accelerated response in the one-way MLR of rabbit WBC from skin allograft recipients. Immunology (1979) 0.75

H-2b bound to egg lecithin liposomes: biochemical and functional properties. Clin Exp Immunol (1982) 0.75

Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11

Evidence for transcriptional regulation of orotidine-5'-phosphate decarboxylase in yeast by hybridization of mRNA to the yeast structural gene cloned in Escherichia coli. Proc Natl Acad Sci U S A (1979) 6.81

One-way stimulation in mixed leukocyte cultures. Science (1966) 6.62

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32

Histocompatibility matching. VI. Miniaturization of the mixed leukocyte culture test: a preliminary report. Transplantation (1971) 5.43

Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59

Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A (1980) 4.35

Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med (2000) 3.41

The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment. Transplant Proc (1973) 3.35

Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. Cell Immunol (1972) 3.35

Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34

Hu-1: Major histocompatibility locus in man. Science (1967) 3.13

Cell mediated immunity: separation of cells involved in recognitive and destructive phases. Science (1973) 3.04

Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med (1968) 3.00

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79

Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 2.79

Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J (1993) 2.75

Detection of a novel human class II HLA antigen. Nature (1983) 2.61

Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40

Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40

Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29

Direct selective techniques for the isolation of pyrimidine auxotrophs in yeast. Mol Gen Genet (1972) 2.28

A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem (1996) 2.26

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med (1991) 2.14

Role of H-2 lymphocyte-defined and serologically-defined components in the generation of cytotoxic lymphocytes. J Exp Med (1974) 2.01

Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00

A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media. J Immunol Methods (1973) 1.97

Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response. Cell Immunol (1970) 1.97

The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92

HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes. Science (1975) 1.91

Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89

Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum Immunol (1984) 1.83

Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone. J Immunol (1975) 1.83

Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82

Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants. Nature (1985) 1.82

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. J Clin Oncol (2000) 1.79

Lymphocyte reactivity in vitro. II. Soluble reconstituting factor permitting response of purified lymphocyte. Cell Immunol (1970) 1.74

Antigen-driven helper cell-independent cloned cytolytic T lymphocytes. Nature (1981) 1.72

Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R. J Exp Med (1992) 1.72

Allogeneic and xenogeneic response in mixed leukocyte cultures. J Exp Med (1972) 1.70

Five HLA-D clusters associated with HLA-DR4. Hum Immunol (1982) 1.70

Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2. Cancer Res (1990) 1.69

Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J Immunol (1987) 1.65

Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature (1976) 1.64

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer (1997) 1.63

Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62

Specificity of allogeneic cell recognition by human lymphocytes in vitro. Science (1971) 1.62

Cell kinetic studies in mixed leukocyte cultures: an in vitro model of homograft reactivity. Proc Natl Acad Sci U S A (1969) 1.61

Lymphocyte studies in congenital thymic dysplasia: The one-way stimulation test. J Pediatr (1968) 1.59

The molecular basis of alloreactivity. Immunol Today (1990) 1.56

Use of HLA loss mutants to analyse the structure of the human major histocompatibility complex. Nature (1982) 1.56

Mouse cell-mediated lympholysis assay in serum-free and mouse serum-supplemented media: culture conditions and genetic factors. Scand J Immunol (1975) 1.55

Genetic control of cell-mediated lympholysis in mouse. J Exp Med (1974) 1.51

Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way. Blood (1994) 1.50

TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol (1980) 1.50

Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J Exp Med (1990) 1.50

Alternative pathways of T lymphocyte activation. J Exp Med (1978) 1.49

Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med (1996) 1.49

Call for moratorium on xenotransplants. Nature (1998) 1.48

Specificity of antigen recognition by human lymphocytes in vitro. Science (1970) 1.48

Continuous culture of T cells cytotoxic for autologous human leukaemia cells. Nature (1979) 1.46

Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. Nat New Biol (1973) 1.44

Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes (2001) 1.43

Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42

Dw/LD-related molecular polymorphism of DR4 beta-chains. J Exp Med (1983) 1.42

Appropriate and necessary healthcare: new language for a new era. Am J Manag Care (1997) 1.42

Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leukoc Biol (1989) 1.41

Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41

Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells. Nature (1978) 1.41

Biosynthesis of dipicolinic acid in sporulating Bacillus megaterium. J Biol Chem (1966) 1.40

SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines. Nature (1981) 1.40

Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1993) 1.35

Human lymphocytes recognise mouse alloantigens. Nature (1975) 1.31

Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem (1996) 1.30

Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens. Cancer Res (1989) 1.29

Transplantation: pairing of donor and recipient. Science (1970) 1.28

The major histocompatibility complex - genetics and biology (third of three parts). N Engl J Med (1976) 1.28

A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood (1998) 1.27

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients. Clin Cancer Res (1997) 1.27

Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26

Cytotoxicity: specificity after in vitro sensitization. Science (1970) 1.26

Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem (1995) 1.26

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta. J Immunol (1987) 1.26

Do morphological anomalies reflect chromosomal aneuploidies?: case report. Hum Reprod (2000) 1.25